Underactive Bladder Syndrome Treatment
Mar 16, 2026
The Underactive Bladder Syndrome Treatment Landscape: Few Contenders, High Unmet Need
Summary The current treatment landscape for underactive bladder largely depends on pharmacological management and catheterization. Despite the significant unmet need, the clinical development pipeline for UAB remains relatively sparse. Notable candidates include TAC-302, being developed by Taiho Pharmace...
Read More...
-Agonist.png "Toll-like Receptors Agonist")
